RESUMEN
The contribution of specific factors to bacterial virulence is generally investigated through creation of genetic "knockouts" that are then compared to wild-type strains or complemented mutants. This paradigm is useful to understand the effect of presence vs. absence of a specific gene product but cannot account for concentration-dependent effects, such as may occur with some bacterial toxins. In order to assess threshold and dose-response effects of virulence factors, robust systems for tunable expression are required. Recent evidence suggests that the folding free energy (ΔG) of the 5' end of mRNA transcripts can have a significant effect on translation efficiency and overall protein abundance. Here we demonstrate that rational alteration of 5' mRNA folding free energy by introduction of synonymous mutations allows for predictable changes in pneumolysin (PLY) expression by Streptococcus pneumoniae without the need for chemical inducers or heterologous promoters. We created a panel of isogenic S. pneumoniae strains, differing only in synonymous (silent) mutations at the 5' end of the PLY mRNA that are predicted to alter ΔG. Such manipulation allows rheostat-like control of PLY production and alters the cytotoxicity of whole S. pneumoniae on primary and immortalized human cells. These studies provide proof-of-principle for further investigation of mRNA ΔG manipulation as a tool in studies of bacterial pathogenesis.
Asunto(s)
Eritrocitos/metabolismo , Hemólisis , Infecciones Neumocócicas/metabolismo , Pliegue del ARN , ARN Mensajero/genética , Streptococcus pneumoniae/genética , Estreptolisinas/metabolismo , Apoptosis , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Western Blotting , Proliferación Celular , Células Cultivadas , Eritrocitos/citología , Humanos , Técnicas para Inmunoenzimas , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Datos de Secuencia Molecular , Infecciones Neumocócicas/genética , Infecciones Neumocócicas/microbiología , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Ácido Nucleico , Streptococcus pneumoniae/aislamiento & purificación , Factores de Virulencia/genética , Factores de Virulencia/metabolismoRESUMEN
α-Intercalated cells (A-ICs) within the collecting duct of the kidney are critical for acid-base homeostasis. Here, we have shown that A-ICs also serve as both sentinels and effectors in the defense against urinary infections. In a murine urinary tract infection model, A-ICs bound uropathogenic E. coli and responded by acidifying the urine and secreting the bacteriostatic protein lipocalin 2 (LCN2; also known as NGAL). A-IC-dependent LCN2 secretion required TLR4, as mice expressing an LPS-insensitive form of TLR4 expressed reduced levels of LCN2. The presence of LCN2 in urine was both necessary and sufficient to control the urinary tract infection through iron sequestration, even in the harsh condition of urine acidification. In mice lacking A-ICs, both urinary LCN2 and urinary acidification were reduced, and consequently bacterial clearance was limited. Together these results indicate that A-ICs, which are known to regulate acid-base metabolism, are also critical for urinary defense against pathogenic bacteria. They respond to both cystitis and pyelonephritis by delivering bacteriostatic chemical agents to the lower urinary system.
Asunto(s)
Proteínas de Fase Aguda/orina , Infecciones por Escherichia coli/prevención & control , Túbulos Renales Colectores/metabolismo , Lipocalinas/orina , Proteínas Oncogénicas/orina , Proteínas Proto-Oncogénicas/orina , Infecciones Urinarias/prevención & control , Escherichia coli Uropatógena , Equilibrio Ácido-Base , Proteínas de Fase Aguda/deficiencia , Proteínas de Fase Aguda/genética , Animales , Modelos Animales de Enfermedad , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/orina , Femenino , Humanos , Concentración de Iones de Hidrógeno , Hierro/metabolismo , Túbulos Renales Colectores/patología , Lipocalina 2 , Lipocalinas/genética , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Proteínas Oncogénicas/deficiencia , Proteínas Oncogénicas/genética , Receptor Toll-Like 4/metabolismo , Infecciones Urinarias/microbiología , Infecciones Urinarias/orinaRESUMEN
Gardnerella vaginalis, the bacterial species most frequently isolated from women with bacterial vaginosis (BV), produces a cholesterol-dependent cytolysin (CDC), vaginolysin (VLY). At sublytic concentrations, CDCs may initiate complex signaling cascades crucial to target cell survival. Using live-cell imaging, we observed the rapid formation of large membrane blebs in human vaginal and cervical epithelial cells (VK2 and HeLa cells) exposed to recombinant VLY toxin and to cell-free supernatants from growing liquid cultures of G. vaginalis. Binding of VLY to its human-specific receptor (hCD59) is required for bleb formation, as antibody inhibition of either toxin or hCD59 abrogates this response, and transfection of nonhuman cells (CHO-K1) with hCD59 renders them susceptible to toxin-induced membrane blebbing. Disruption of the pore formation process (by exposure to pore-deficient toxoids or pretreatment of cells with methyl-ß-cyclodextrin) or osmotic protection of target cells inhibits VLY-induced membrane blebbing. These results indicate that the formation of functional pores drives the observed ultrastructural rearrangements. Rapid bleb formation may represent a conserved response of epithelial cells to sublytic quantities of pore-forming toxins, and VLY-induced epithelial cell membrane blebbing in the vaginal mucosa may play a role in the pathogenesis of BV.
Asunto(s)
Proteínas Bacterianas/metabolismo , Toxinas Bacterianas/metabolismo , Extensiones de la Superficie Celular/microbiología , Gardnerella vaginalis/metabolismo , Vaginosis Bacteriana/inmunología , Animales , Antígenos CD59/metabolismo , Células CHO , Cuello del Útero/citología , Cuello del Útero/inmunología , Cuello del Útero/microbiología , Cricetulus , Células Epiteliales/citología , Células Epiteliales/metabolismo , Femenino , Gardnerella vaginalis/crecimiento & desarrollo , Gardnerella vaginalis/inmunología , Infecciones por Bacterias Grampositivas , Células HeLa , Humanos , Transducción de Señal , Vagina/citología , Vagina/inmunología , Vagina/microbiología , Vaginosis Bacteriana/microbiología , beta-CiclodextrinasRESUMEN
Group B Streptococcus (GBS; Streptococcus agalactiae) is a major human pathogen that disproportionately affects neonates and women in the peripartum period and is an emerging cause of infection in older adults. The primary toxin of GBS, ß-hemolysin/cytolysin (ßH/C), has a well-defined role in the pathogenesis of invasive disease, but its role in urinary tract infection (UTI) is unknown. Using both in vitro and in vivo models, we analyzed the importance of ßH/C in GBS uropathogenesis. There were no significant differences in bacterial density from the bladders or kidneys from mice infected with wild-type or isogenic ßH/C-deficient GBS, and competitive indices from co-infection experiments were near 1. Thus, ßH/C is dispensable for the establishment of GBS-UTI. However, ßH/C-sufficient GBS induced a more robust proinflammatory cytokine response in cultured bladder epithelial cells and in the urinary tracts of infected mice. Given the near ubiquity of ßH/C-expressing strains in epidemiologic studies and the importance of local inflammation in dictating outcomes and sequelae of UTI, we hypothesize that ßH/C-driven inflammatory signaling may be important in the clinical course of GBS-UTI.
Asunto(s)
Proteínas Bacterianas/metabolismo , Proteínas Hemolisinas/metabolismo , Inflamación/microbiología , Perforina/metabolismo , Infecciones Estreptocócicas/microbiología , Streptococcus agalactiae/metabolismo , Infecciones Urinarias/microbiología , Animales , Proteínas Bacterianas/genética , Línea Celular , Citocinas/biosíntesis , Citocinas/genética , Modelos Animales de Enfermedad , Femenino , Proteínas Hemolisinas/genética , Humanos , Inflamación/metabolismo , Ratones , Membrana Mucosa/metabolismo , Membrana Mucosa/microbiología , Perforina/genética , Infecciones Estreptocócicas/metabolismo , Streptococcus agalactiae/genética , Streptococcus agalactiae/patogenicidad , Factores de Tiempo , Vejiga Urinaria/metabolismo , Vejiga Urinaria/microbiología , Vejiga Urinaria/patología , Infecciones Urinarias/metabolismoRESUMEN
The strong epidemiological association between cigarette smoke (CS) exposure and respiratory tract infections is conventionally attributed to immunosuppressive and irritant effects of CS on human cells. Since pathogenic bacteria such as Staphylococcus aureus are members of the normal microbiota and reside in close proximity to human nasopharyngeal cells, we hypothesized that bioactive components of CS might affect these organisms and potentiate their virulence. Using Staphylococcus aureus as a model organism, we observed that the presence of CS increased both biofilm formation and host cell adherence. Analysis of putative molecular pathways revealed that CS exposure decreased expression of the quorum-sensing agr system, which is involved in biofilm dispersal, and increased transcription of biofilm inducers such as sarA and rbf. CS contains bioactive compounds, including free radicals and reactive oxygen species, and we observed transcriptional induction of bacterial oxidoreductases, including superoxide dismutase, following exposure. Moreover, pretreatment of CS with an antioxidant abrogated CS-mediated enhancement of biofilms. Exposure of bacteria to hydrogen peroxide alone increased biofilm formation. These observations are consistent with the hypothesis that CS induces staphylococcal biofilm formation in an oxidant-dependent manner. CS treatment induced transcription of fnbA (encoding fibronectin binding protein A), leading to increased binding of CS-treated staphylococci to immobilized fibronectin and increased adherence to human cells. These observations indicate that the bioactive effects of CS may extend to the resident microbiota of the nasopharynx, with implications for the pathogenesis of respiratory infection in CS-exposed humans.
Asunto(s)
Biopelículas , Estrés Oxidativo/fisiología , Fumar/efectos adversos , Infecciones Estafilocócicas/metabolismo , Staphylococcus aureus/efectos de los fármacos , Adhesinas Bacterianas/efectos de los fármacos , Proteínas Bacterianas/metabolismo , Línea Celular , Regulación Bacteriana de la Expresión Génica , Humanos , Staphylococcus aureus/genética , Staphylococcus aureus/patogenicidad , Staphylococcus aureus/fisiología , Transcripción Genética , Virulencia/efectos de los fármacosRESUMEN
The incidence of Candida albicans infections and the relapse episodes after antifungal treatment have increased in recent decades. Recurrences are mainly due to the persistence of the original infecting strain that may present genetic and genomic rearrangements during interaction with the host, reflecting strain adaptation. In this study, four isolates recovered from a patient during recurrent candidemia episodes were genotyped by microsatellite length polymorphism (MLP) and by multilocus sequence typing (MLST) and found to be genetic variants of the same strain. Using experimental mouse infections, a progressive reduction in the virulence of the four isolates was observed, with the first two isolates more virulent than the third and fourth. Additionally, in the mouse model, the first isolate resisted host control more efficiently, resulting in higher kidney fungal burdens and necrosis as compared to the third isolate. The resolution of inflammation was delayed in mice challenged with the first isolate and the message for IFN-gamma and TNF-alpha in the spleen was lower within the first few hours post-infection. Original and recurrent isolates also displayed different phenotypes regarding activity of secreted enzymes and response to stress agents. Overall, the comparative analysis indicated that the virulence decrease of these isolates was related to a lower ability to resist to the host anticandida effector mechanisms. We showed for the first time that C. albicans genetic variants of the same strain, sequentially isolated from an immunocompromised patient, underwent adaptations in the human host that resulted in virulence attenuation when tested in mice.